| [1] |
Aschner P, Karuranga S, James S, et al. The international diabetes federation’s guide for diabetes epidemiological studies[J]. Diabetes Res Clin Pract, 2021, 172:108630.
|
| [2] |
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants[J]. Lancet, 2016, 387(10027): 1513-1530.
|
| [3] |
Magliano DJ, Boyko EJ, IDF diabetes atlas 10th edition scientific committee. IDF Diabetes Atlas[R]. 10th ed. Brussels: International Diabetes Federation, 2021.
|
| [4] |
World Health Organization. Classification of diabetes mellitus 2019[R]. Gevena: World Health Organization, 2019.
|
| [5] |
ElSayed NA, Aleppo G, Aroda VR, et al. 2. Classification and diagnosis of diabetes: Standards of care in diabetes-2023[J]. Diabetes care, 2023, 46(Suppl 1): S19-S40.
|
| [6] |
Himsorth HP. Diabetes mellitus: Its differentiation into insulin-sensitive and insulin-insensitive types. 1936[J]. Int J Epidemiol, 2013, 42(6): 1594-1598.
doi: 10.1093/ije/dyt203
pmid: 24415598
|
| [7] |
孙颖, 邵丹青. 成人糖尿病分型及健康管理应用[J]. 慢性病学杂志, 2023, 24(2): 214-219.
|
| [8] |
Gorden P. Non-insulin dependent diabetes--the past, present and future[J]. Ann Acad Med Singap, 1997, 26(3): 326-330.
pmid: 9285027
|
| [9] |
王继伟, 徐望红, 王继伟.等. 我国慢性病防治成功案例——中国大庆糖尿病预防研究的分析及启示[J]. 中华内分泌代谢杂志, 2013,29(3):196-199
|
| [10] |
Eriksson J, Lindström J, Valle T, et al. Prevention of Type II diabetes in subjects with impaired glucose tolerance: The Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme[J]. Diabetologia, 1999, 42(7): 793-801.
pmid: 10440120
|
| [11] |
Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin[J]. N Engl J Med, 2002, 346(6): 393-403.
|
| [12] |
Alberti KG, Zimmet PZ. efinition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J]. Diabet Med, 1998, 15(7): 539-553.
|
| [13] |
Ahlqvist E, Storm P, Käräjämäki A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: A data-driven cluster analysis of six variables[J]. Lancet Diabetes Endocrinol, 2018, 6(5): 361-369.
|
| [14] |
裴晓蓓. 成人糖尿病国际新分型及其对临床用药的指导分析[J]. 临床合理用药杂志, 2019, 12(14): 169-170.
|
| [15] |
Dennis JM, Shield BM, Henley WE, et al. Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: An analysis using clinical trial data[J]. Lancet Diabetes Endocrinol, 2019, 7(6): 442-451.
|
| [16] |
Zou X, Zhou X, Zhu Z, et al. Novel subgroups of patients with adult-onset diabetes in Chinese and US populations[J]. Lancet Diabetes Endocrinol, 2019, 7(1): 9-11.
|
| [17] |
潘锋. 聚类分型有利于实现糖尿病精准管理和治疗——访北京大学人民医院内分泌科主任纪立农教授[J]. 中国当代医药, 2019, 26(19): 1-3.
|
| [18] |
Li X, Yang S, Cao C, et al. Validation of the swedish diabetes re-grouping scheme in adult-onset diabetes in China[J]. J Clin Endocrinol Metab, 2020, 105(10):dgaa524.
|
| [19] |
Zaharia OP, Strassburger K, Strom A, et al. Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: A 5-year follow-up study[J]. Lancet Diabetes Endocrinol, 2019, 7(9): 684-694.
|
| [20] |
Tanabe H, Saito H, Kudo A, et al. Factors associated with risk of diabetic complications in novel cluster-based diabetes subgroups: A Japanese retrospective cohort study[J]. J Clin Med, 2020, 9(7):2083.
|
| [21] |
Safai N, Ali A, Rossing P, et al. Stratification of type 2 diabetes based on routine clinical markers[J]. Diabetes Res Clin Pract, 2018, 141: 275-283.
|
| [22] |
Segar MW, Patel KV, Vaduganathan M, et al. Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetes[J]. Diabetologia, 2021, 64(7): 1583-1594.
doi: 10.1007/s00125-021-05426-2
pmid: 33715025
|
| [23] |
中国医师协会内分泌代谢科医师分会, 国家代谢性疾病临床医学研究中心. 糖尿病分型诊断中国专家共识[J]. 中华糖尿病杂志, 2022, 14(2):120-139.
|
| [24] |
Guo Y, Zhao X, Liu CQ, et al. A novel refined classification system for type 2 diabetes in adults: A Chinese retrospective cohort study[J]. Diabetes Metab Res Rev, 2022, 38(8): e3577.
|
| [25] |
Huang Y, Wang Y, Liu C, et al. C-peptide, glycaemic control, and diabetic complications in type 2 diabetes mellitus: A real-world study[J]. Diabetes Metab Res Rev, 2022, 38(4): e3514.
|
)
